TAG:
LabCorp
Lab Briefs: Dec. 16, 2024
By Robert Michel | From the Volume XXXI, No. 17 – December 16, 2024 Issue
55,000 Members of Class Action Case Involving Labcorp…
November 25, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, No. 16 – November 25, 2024 Issue
Disruption is happening in the consumer genetic testing marketplace. In recent weeks, news outlets in the United Kingdom reported that Atlas Biomed, a consumer genetic testing company founded in 2016, had simply “disappeared.” Malwarebytes said Atlas Biomed’s “London offices …
Getting Test Claims Paid & Class Action Lawsuits
By R. Lewis Dark | From the Volume XXXI No. 15 – November 4, 2024 Issue
When you crack open this issue of The Dark Repor…
Internet Tracking Lawsuits Target Quest and Labcorp
By Robert Michel | From the Volume XXXI No. 15 – November 4, 2024 Issue
CEO SUMMARY: Here is the clinical lab industry’s first intelligence briefing on how class action attorneys are filing lawsuits against healthcare providers—including clinical laboratories. The allegations are that providers are using internet tracking tools, such as those offered by M…
Insights from Q3 2024 Earnings Calls Point to a More Robust Lab Market
By Robert Michel | From the Volume XXXI No. 15 – November 4, 2024 Issue
FOR THE THIRD QUARTER OF 2024 (Q3 2024), both of the nation’s largest publicly traded laboratories—Labcorp…
Allina Doctors Express Concerns after Quest Acquires Lab Outreach
By Robert Michel | From the Volume XXXI, No. 14 – October 14, 2024 Issue
IN RECENT YEARS, QUEST DIAGNOSTICS AND LABCORP, the two behemoths of the U.S. clinical laboratory market, have been aggressively acquiring lab businesses from health systems across the country. They say that patients and providers will benefit from lower costs and be…
Hospital Lab Outreach: Still a Valuable Asset!
By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue
CEO SUMMARY: Hospital lab administrators everywhere are watching press releases announcing the latest agreement of a major health system selling its laboratory outreach business to one of the billion-dollar lab corporations. The pace of these sales is accelerating. These deals confirm the…
September 23, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, No. 13 – September 23, 2024 Issue
One sign of the financial turmoil associated with the market for genetic tests is the news that all seven independent directors of 23andMe’s board resigned at the same time on Sept. 18. The reason given was that these directors opposed the plan of CEO and co-founder Anne Wojcicki t…
September 3, 2024, Intelligence: Late-Breaking Lab News
By Robert Michel | From the Volume XXXI, No. 12 – September 3, 2024 Issue
To challenge the federal Food and Drug Administration (FDA) final rule on laboratory developed tests (LDTs,) the Association for Molecular Pathology (AMP) filed a lawsuit on August 20, 2024, in the United States District Court for the Southern District of Tex…
Identifying Current Lab Trends from Labcorp & Quest Experience
By Robert Michel | From the Volume XXXI, No. 11 – August 12, 2024 Issue
CEO SUMMARY: Many different factors influence the operations of clinical laboratories in the United States today. One good source of competitive business intelligence is for lab administrators to follow the quarterly earnings calls of the nation’s two biggest public lab corporations. Wi…
CURRENT ISSUE

Volume XXXII, No. 9 – June 23, 2025
In part one of an analysis about the state of AI in clinical laboratories, The Dark Report explores how frontline workers, especially younger ones, are using AI tools like ChatGPT far more than lab leaders. Recent reports elsewhere in the business world show executives underestimate staff AI use, raising concerns about a leadership gap in tech adoption. Clinical lab leaders must get more familiar with AI use cases. Also, in this issue of The Dark Report, there is discussion on how Medicaid cuts may affect clinical labs, an examination of the lab industry fallout from CLIAC termination, an analysis of AMP’s reports that provide crucial insights for Hiring Managers, and notes that regional health systems are new dominant players in M&A.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized